| For: | Silva-Veiga FM, Miranda CS, Vasques-Monteiro IML, Souza-Tavares H, Martins FF, Daleprane JB, Souza-Mello V. Peroxisome proliferator-activated receptor-alpha activation and dipeptidyl peptidase-4 inhibition target dysbiosis to treat fatty liver in obese mice . World J Gastroenterol 2022; 28(17): 1814-1829 [PMID: 35633911 DOI: 10.3748/wjg.v28.i17.1814] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v28/i17/1814.htm |
| Number | Citing Articles |
| 1 |
Juliane Colombo Carrer de Macedo, Dioze Guadagnini, Heloisa B. Assalin, Emília Sousa Oliveira, Daniela O. Magro, Marcos R. Alborghetti, Maurício L. Sforça, Silvana A. Rocco, Andrey Santos, Mario J. A. Saad. Vildagliptin modulates the microbiota and induces an immunometabolic profile compatible with neuroprotection in type 2 diabetes. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-12990-9
|
| 2 |
Sevag Hamamah, Oana C. Iatcu, Mihai Covasa. Dietary Influences on Gut Microbiota and Their Role in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). Nutrients 2024; 17(1) doi: 10.3390/nu17010143
|
| 3 |
Mahtab Mehboodi, Milad PourMohammadAli Namdari, Zeynab Abdollahi, Zahra Mobarezi, Maedeh Kiani, Forozan Chamani, Hadis Khanbabaie, Saman Rabiei, Mohammad Hasan Maleki, Hamidreza Sanati, Golshid Javdani Shahedin, Elham Isaei. The relationship between increased levels of microbiota-derived lipopolysaccharide in obesity and the pathophysiology of neurodegenerative diseases. Microbial Pathogenesis 2025; 207 doi: 10.1016/j.micpath.2025.107905
|
| 4 |
Henrique Souza-Tavares, Carolline Santos Miranda, Isabela Macedo Lopes Vasques-Monteiro, Cristian Sandoval, Daiana Araujo Santana-Oliveira, Flavia Maria Silva-Veiga, Aline Fernandes-da-Silva, Vanessa Souza-Mello. Peroxisome proliferator-activated receptors as targets to treat metabolic diseases: Focus on the adipose tissue, liver, and pancreas. World Journal of Gastroenterology 2023; 29(26): 4136-4155 doi: 10.3748/wjg.v29.i26.4136
Abstract(1060) |
Core Tip(1032) |
Full Article(HTML)(7112)
|
Full Article (PDF)-2462K(496)
|
Full Article with Cover (PDF)-2727K(341)
|
Full Article (Word)-1960K(59)
|
Full Article (XML)-372K(245)
|
Audio-581K(23)
|
Peer-Review Report-312K(202)
|
Answering Reviewers-111K(179)
|
Times Cited (38)
|
Total Visits (9965)
|
Open
|
| 5 |
Xili Fu, Yinyin Xie, Yi Xie, Aoya Han, Xinru Zhou, Shijie Zhang, Changchang Shen, Yuxuan Zhang, Lina Wang, Nanchang Xie. DPP-4 inhibitors in drug-resistant epilepsy: a hypothesized mechanism via the gut microbiota-short-chain fatty acids-glucagon-like peptide-1 axis. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1860661
|
| 6 |
Yuan Zeng, Yifan Wu, Qian Zhang, Xinhua Xiao, Marcio Rodrigues. Crosstalk between glucagon-like peptide 1 and gut microbiota in metabolic diseases. mBio 2024; 15(1) doi: 10.1128/mbio.02032-23
|
| 7 |
Yafei Yang, Furong Zhang, Zhuang Peng, Yafei Wu, Ling Li, Zixia Shen, Qifa Ye, Jiang Yue, Shufang Na. Emerging insights into PPARα′s role in lean metabolic dysfunction-associated steatotic liver disease: Implications for targeted therapies. Acta Pharmaceutica Sinica B 2026; doi: 10.1016/j.apsb.2026.06.029
|
| 8 |
Shukun Liang, Jintao Sun, Xinshu Gu, Ya Zhao, Xiumin Wang, Hui Tao, Zhenlong Wang, Yougang Zhong, Jinquan Wang, Bing Han. Lactobacillus plantarum L11 and Lactobacillus reuteri LR: Ameliorate Obesity via AMPK Pathway. Nutrients 2024; 17(1) doi: 10.3390/nu17010004
|
| 9 |
Maja Grabacka, Przemysław M. Płonka, Małgorzata Pierzchalska. The PPARα Regulation of the Gut Physiology in Regard to Interaction with Microbiota, Intestinal Immunity, Metabolism, and Permeability. International Journal of Molecular Sciences 2022; 23(22) doi: 10.3390/ijms232214156
|
| 10 |
Abhishek Satheesan, Janardanan Kumar, Kakithakara Vajravelu Leela, Ria Murugesan, Venkata Chaithanya, Matcha Angelin. Review on the role of nucleotide-binding oligomerization domain-like receptor protein 3 (NLRP3) inflammasome pathway in diabetes: mechanistic insights and therapeutic implications. Inflammopharmacology 2024; 32(5) doi: 10.1007/s10787-024-01556-2
|
| 11 |
Pınar Kar, Gülay Çiftci, Alper Çiftci. Potential benefit of Lactobacillus acidophilus supplementation to rats fed with a high-fat diet on serum lipid profile, kidney amyloid protein and tumor necrosis factor-alpha level. Prostaglandins & Other Lipid Mediators 2024; 175 doi: 10.1016/j.prostaglandins.2024.106911
|
| 12 |
Haoran Jiang, Linquan Zang. GLP-1/GLP-1RAs: New Options for the Drug Treatment of NAFLD. Current Pharmaceutical Design 2024; 30(2) doi: 10.2174/0113816128283153231226103218
|
| 13 |
Laura Alexia Ramos-da-Silva, Henrique Souza-Tavares, Gabriela Rodrigues Medeiros, Nathan Soares Dantas-Miranda, Gabrielle Lima-de-Figueiredo, Daiana Araujo Santana-Oliveira, Flavia Maria Silva-Veiga, Fabiane Ferreira Martins, Vanessa Souza-Mello. Gut-liver axis: An emerging target for exercise in obesity management. Clinics and Research in Hepatology and Gastroenterology 2025; 49(9) doi: 10.1016/j.clinre.2025.102687
|
| 14 |
Rong Xu, Difei Lian, Yan Xie, Zhilei Chen, Yan Wang, Lin Mu, Yuan Wang, Baoyu Zhang. SGLT-2 Inhibitors for Non-Alcoholic Fatty Liver Disease: A Review. Frontiers in Bioscience-Landmark 2023; 28(7) doi: 10.31083/j.fbl2807134
|
| 15 |
Tamiris Ingrid Petito‐da‐Silva, Felipe Missiba Villardi, Aline Penna‐de‐Carvalho, Carlos Alberto Mandarim‐de‐Lacerda, Vanessa Souza‐Mello, Sandra Barbosa‐da‐Silva. An Intestinal FXR Agonist Mitigates Dysbiosis, Intestinal Tight Junctions, and Inflammation in High‐Fat Diet‐Fed Mice. Molecular Nutrition & Food Research 2024; 68(4) doi: 10.1002/mnfr.202300148
|
| 16 |
Ming Yang, Shuai Liu, Chunye Zhang. The Related Metabolic Diseases and Treatments of Obesity. Healthcare 2022; 10(9) doi: 10.3390/healthcare10091616
|
| 17 |
Isabela Macedo Lopes Vasques-Monteiro, Aline Fernandes-da-Silva, Carolline Santos Miranda, Flavia Maria Silva-Veiga, Julio Beltrame Daleprane, Vanessa Souza-Mello. Anti-steatotic effects of PPAR-alpha and gamma involve gut-liver axis modulation in high-fat diet-fed mice. Molecular and Cellular Endocrinology 2024; 585 doi: 10.1016/j.mce.2024.112177
|
| 18 |
Vanessa Souza-Mello, Flavia Maria Silva-Veiga, Jade Sancha de Oliveira Glauser, Nathan Soares Dantas-Miranda, Isabela Lopes Vasques-Monteiro, Daiana Araujo Santana-Oliveira, Carolline Santos Miranda. Time-dependent impact of a high-fat diet on the intestinal barrier of male mice. World Journal of Methodology 2024; 14(1): 89723 doi: 10.5662/wjm.v14.i1.89723
|
| 19 |
Chao Cui, Shuai Gao, Jingfei Shi, Kai Wang. Gut-Liver Axis: The Role of Intestinal Microbiota and Their Metabolites in the Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease. Gut and Liver 2025; 19(4) doi: 10.5009/gnl240539
|
| 20 |
Qiuyu Xu, Jie Zhang, Yan Lu, Ling Wu. Association of metabolic-dysfunction associated steatotic liver disease with polycystic ovary syndrome. iScience 2024; 27(2) doi: 10.1016/j.isci.2024.108783
|
| 21 |
Anna S. Stepanova, Ilmir A. Shaidullin, Liliya R. Sharafutdinova, Evgeny G. Prokopyev, Yulia R. Romanova, Renata I. Murzakaeva, Kseniya A. Gerasimova, Sofia A. Safina, Elina R. Abdrakhmanova, Yana M. Samatova, Ekaterina S. Bashlykova, Maria V. Naumova. The role of exercise intensity in the regulation of the gut microbiota and liver function in metabolic dysfunction–associated steatotic liver disease. Russian Journal of Physiotherapy, Balneology and Rehabilitation 2026; 25(2) doi: 10.17816/rjpbr694105
|
| 22 |
Zhangkui Tan, Lifeng Chen, Zhiqin Ye, Qiping Lu. Xiaohuang Qudan decoction alleviates ANIT-induced cholestatic liver injury by inhibiting the JAK2/STAT3 pathway and regulating TH17/Treg. Chinese Journal of Natural Medicines 2025; 23(4) doi: 10.1016/S1875-5364(25)60854-5
|
| 23 |
Vincenzo Trapanese, Annamaria Dagostino, Maria Resilde Natale, Federica Giofrè, Clara Vatalaro, Melania Melina, Francesca Cosentino, Silvia Sergi, Felice Imoletti, Rocco Spagnuolo, Franco Arturi. Bidirectional Interactions Between the Gut Microbiota and Incretin-Based Therapies. Life 2025; 15(6) doi: 10.3390/life15060843
|
| 24 |
Pavan K. Mantravadi, Basavaraj S. Kovi, Sabbasani Rajasekhara Reddy, Ganesh Pandian Namasivayam, Karunakaran Kalesh, Anutthaman Parthasarathy. Probing and manipulating the gut microbiome with chemistry and chemical tools. Gut Microbiome 2025; 6 doi: 10.1017/gmb.2025.4
|
| 25 |
Zhuoqun Meng, Qin Zhang, Zhichang Zhao, Yuan Zhang, Zhijie Lu, Guirong Liu, Wenliang Xiang, Qing Zhang, Jie Tang. Sinensetin ameliorates established high-fat diet-induced liver injury and intestinal barrier dysfunction through the mitophagy/TLR4/MAPK signaling pathway. Frontiers in Nutrition 2026; 13 doi: 10.3389/fnut.2026.1812651
|